Saturday - October 18, 2025
Foundations

Here's a look at documents from U.S. foundations

Featured Stories

New Coastwide Menhaden Science Estimates Smaller Population, Indicates Major Catch Reductions Needed
ANNAPOLIS, Maryland, Oct. 18 -- The Chesapeake Bay Foundation posted the following news release on Oct. 17, 2025:

* * *

New Coastwide Menhaden Science Estimates Smaller Population, Indicates Major Catch Reductions Needed

Fisheries Regulators to Consider New Coastwide Harvest Limits, Chesapeake Bay Management

*

There are fewer menhaden along the Atlantic Coast than previously thought, leading to potential major catch reductions, according to scientific assessments released this week ahead of a fisheries regulators meeting.

Forecasts show that the menhaden catch must be cut in half to provide ... Show Full Article

Foundation for Economic Education Issues Commentary: New Pacific Trade Highway
DETROIT, Michigan, Oct. 18 -- The Foundation for Economic Education posted the following commentary on Oct. 17, 2025:

* * *

A New Pacific Trade Highway

The remapping of global supply chains.

By Jake Scott

When President Trump announced a new 100% tariff on Chinese imports, in retaliation for Beijing's latest export controls on rare earth elements, markets saw only the headline risk. But the real story lies beyond the ticker: a structural reordering of global trade. The world's supply chains, long anchored to the Chinese mainland, are splintering.

Capital is scattering across Asia's periphery, ... Show Full Article

Annual Funded Grants - CRISPR and Prime Editing Technologies
COLUMBIA, Maryland, Oct. 18 -- The Foundation Fighting Blindness issued the following news on Oct. 17, 2025:

* * *

Annual Funded Grants - CRISPR and Prime Editing Technologies

Funded grants for CRISPR and prime editing approaches.

*

The Foundation Fighting Blindness is proud to announce funding for several projects based on CRISPR and prime editing technologies.

* Stephen Tsang - $200,000

Columbia University

"ARMS2/HTRA1 in non-cell-autonomous oxidative and anti-inflammatory therapeutic targeting"

Drs. Tsang and Olah will use CRISPR to identify the causative allele of AMD pathologies and ... Show Full Article

WLF Asks Fifth Circuit to Grant En Banc Rehearing in Constitutional Challenge to FDIC's Structure
WASHINGTON, Oct. 17 -- The Washington Legal Foundation issued the following news release on Oct. 16, 2025:

* * *

WLF Asks Fifth Circuit to Grant En Banc Rehearing in Constitutional Challenge to FDIC's Structure

"The panel's decision allows agencies to evade constitutional scrutiny and shields structural flaws from timely Article III review."

--Cory Andrews, WLF General Counsel & Vice President of Litigation

*

Washington Legal Foundation (WLF) today urged the U.S. Court of Appeals for the Fifth Circuit to grant rehearing en banc to revisit a panel's flawed ruling that federal courts lack jurisdiction ... Show Full Article

Reason Foundation Issues Commentary: Best Practices to Prevent Misuse of Opioid Settlement Funds
LOS ANGELES, California, Oct. 17 -- The Reason Foundation issued the following commentary on Oct. 16, 2025:

* * *

Best practices to prevent misuse of opioid settlement funds

States should adopt clear guidelines to ensure settlement funds support evidence-based treatment and recovery.

By Layal Bou Harfouch, Drug Policy Analyst; and Mariana Trujillo, Managing Director

To address the damages caused by the growing opioid epidemic, state and local governments filed thousands of lawsuits against opioid manufacturers, distributors, and retailers, accusing them of fueling the crisis through misleading ... Show Full Article

Compared to Standard of Care: Phase 3 MajesTEC-3 Study Reveals TECVAYLI Plus DARZALEX FASPRO Combination Significantly Improves PFS, Overall Survival
NORTH HOLLYWOOD, California, Oct. 17 (TNSrep) -- The International Myeloma Foundation issued the following news on Oct. 16, 2025:

* * *

Compared to Standard of Care: Phase 3 MajesTEC-3 study reveals TECVAYLI plus DARZALEX FASPRO combination significantly improves PFS and overall survival

According to Johnson & Johnson, results of the Phase 3 MajesTEC-3 study reveal TECVAYLI(R) plus DARZALEX FASPRO(R) combination significantly improves PFS and overall survival.

On Thursday, October 16, Johnson & Johnson announced "positive topline results from the investigational Phase 3 MajesTEC-3 study" via ... Show Full Article

AmfAR Awards $2.4M in New HIV Cure-Focused Research Grants
NEW YORK, Oct. 17 -- AmfAR-the Foundation for AIDS Research issued the following news release:

* * *

amfAR Awards $2.4 Million in New HIV Cure-Focused Research Grants

Research teams in North America, Africa, and Australia will receive support to test a range of bold and innovative cure strategies

*

amfAR, The Foundation for AIDS Research, announced a new round of grants Thursday to research teams across three continents targeting novel HIV cure strategies. It marks the first time amfAR has funded five grants in a single round, reaffirming the organization's commitment to funding bold, innovative ... Show Full Article